Translation of "The Orly Group " (English → French) :

Definition: This block contains a wide variety of disorders that differ in severity and clinical form but that are all attributable to the use of one or more psychoactive substances, which may or may not have been medically prescribed. The third character of the code identifies the substance involved, and the fourth character specifies the clinical state. The codes should be used, as required, for each substance specified, but it should be noted that not all fourth character codes are applicable to all substances. Identification of the psychoactive substance should be based on as many sources of information as possible. These include self-report data, analysis of blood and other body fluids, characteristic physical and psychological symptom ...[+++]s, clinical signs and behaviour, and other evidence such as a drug being in the patient's possession or reports from informed third parties. Many drug users take more than one type of psychoactive substance. The main diagnosis should be classified, whenever possible, according to the substance or class of substances that has caused or contributed most to the presenting clinical syndrome. Other diagnoses should be coded when other psychoactive substances have been taken in intoxicating amounts (common fourth character .0) or to the extent of causing harm (common fourth character .1), dependence (common fourth character .2) or other disorders (common fourth character .3-.9). Only in cases in which patterns of psychoactive substance-taking are chaotic and indiscriminate, or in which the contributions of different psychoactive substances are inextricably mixed, should the diagnosis of disorders resulting from multiple drug use (F19.-) be used. | Modifiers The following fourth-character subdivisions are for use with categories F10-F19: Code Title .0 Acute intoxication A condition that follows the administration of a psychoactive substance resulting in disturbances in level of consciousness, cognition, perception, affect or behaviour, o ...

Definition: Disorder involving persistent dissocial or aggressive behaviour (meeting the overall criteria for F91.- and not merely comprising oppositional, defiant, disruptive behaviour) occurring in individuals who are generally well integrated into their peer group. | Conduct disorder, group type Group delinquency Offences in the context of gang membership Stealing in company with others Truancy from school

A rare genetic axonal peripheral sensorimotor neuropathy with an X-linked recessive inheritance pattern and the neonatal to early childhood-onset of severe, slowly progressive, distal muscle weakness and atrophy (in particular of the peroneal group)

Definition: A wide variety of medicaments and folk remedies may be involved, but the particularly important groups are: (a) psychotropic drugs that do not produce dependence, such as antidepressants, (b) laxatives, and (c) analgesics that may be purchased without medical prescription, such as aspirin and paracetamol. Persistent use of these substances often involves unnecessary contacts with medical professionals or supporting staff, and is sometimes accompanied by harmful physical effects of the substances. Attempts to dissuade or forbid the use of the substance are often met with resistance; for laxatives and analgesics this may be in ...[+++] spite of warnings about (or even the development of) physical harm such as renal dysfunction or electrolyte disturbances. Although it is usually clear that the patient has a strong motivation to take the substance, dependence or withdrawal symptoms do not develop as in the case of the psychoactive substances specified in F10-F19. | Abuse of:antacids | herbal or folk remedies | steroids or hormones | vitamins | Laxative habit

Automotive Crisis Group | Future of the Automotive Industry Interregional Group | Interregional group on the Future of the Automotive Industry | Interregional Group on the Future of the Automotive Industry in our Territories

Describes a rare group of immunodeficiencies due to specific mutations in the inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma (IKBKG) or the cytochrome b-245, beta polypeptide (CYBB) genes. The clinical manifestation is my

Charcot-Marie-Tooth disease, type 4F (CMT4F) is a demyelinating CMT peripheral sensorimotor polyneuropathy. It is a rare form of CMT4 but the few reported families are from diverse ethnic groups: Lebanese Shiite Muslims, Hispanic North Americans, Nor

Friends of the Presidency Group (MFF Review/Revision) | Friends of the Presidency Group (Multiannual Financial Framework Review/Revision) | Friends of the Presidency Group (Multiannual Financial Framework Review/Revision/Omnibus financial regulation) | Friends of the Presidency Group (Multiannual Financial Framework)

Open-Ended Working Group of the Parties to the Montreal Protocol | Open-Ended Working Group of the Parties to the Montreal Protocol on Substances that Deplete the Ozone Layer

work with group at the circus | work with the group of the circus | collaborate with circus members | work with circus group

The following spoke: Manfred Weber, on behalf of the PPE Group, Gianni Pittella, on behalf of the SD Group, Syed Kamall, on behalf of the ECR Group, Guy Verhofstadt, on behalf of the ALDE Group, Patrick Le Hyaric, on behalf of the GUE/NGL Group, Philippe Lamberts, on behalf of the Verts/ALE Group, Nigel Farage, on behalf of the EFDD Group, Harald Vilimsky, on behalf of the ENF Group, and Konstantinos Papadakis, non-attached Member.

The following spoke: Ruža Tomašić (rapporteur for the opinion of the REGI Committee), Krišjānis Kariņš, on behalf of the PPE Group, Dan Nica, on behalf of the SD Group, Edward Czesak, on behalf of the ECR Group, Pavel Telička, on behalf of the ALDE Group, Xabier Benito Ziluaga, on behalf of the GUE/NGL Group, Claude Turmes, on behalf of the Verts/ALE Group, Christelle Lechevalier, on behalf of the ENF Group, who declined a blue-card question from Claude Turmes, Zoltán Balczó, non-attached Member, András Gyürk, Martina Werner and Jaromír Kohlíček.

The following spoke: Michaela Šojdrová, on behalf of the PPE Group, Silvia Costa, on behalf of the SD Group, Kazimierz Michał Ujazdowski, on behalf of the ECR Group, Ilhan Kyuchyuk, on behalf of the ALDE Group, Curzio Maltese, on behalf of the GUE/NGL Group, Patrick O'Flynn, on behalf of the EFDD Group, Dominique Bilde, on behalf of the ENF Group, Diane Dodds, non-attached Member, Milan Zver, Krystyna Łybacka, Notis Marias, Liadh Ní Riada, Bogdan Brunon Wenta, Julie Ward, Theodoros Zagorakis, Luigi Morgano, Santiago Fisas Ayxelà, Francis Zammit Dimech, Lara Comi and Jiří Pospíšil.

Sirpa Pietikäinen, on behalf of the PPE Group, Renata Briano, on behalf of the SD Group, Mark Demesmaeker, on behalf of the ECR Group, Catherine Bearder, on behalf of the ALDE Group, Anja Hazekamp, on behalf of the GUE/NGL Group, Keith Taylor, on behalf of the Verts/ALE Group and Eleonora Evi, on behalf of the EFDD Group, on whale hunting in Norway (2017/2712(RSP)) (B8-0499/2017).